Epidemiology, impact on oncologic treatments, and management of community-acquired respiratory virus (CARV) infections in pediatric onco-hematology patients: a survey among Italian pediatric oncology hematology centres (AIEOP)
Abstract
Abstract A survey was conducted across Italian Pediatric Onco‑Hematology centres to assess epidemiology of community‑acquired respiratory virus (CARV) infections, chemotherapy management, Oseltamivir use and vaccination policies. Most reported infections were mild and managed outpatients, and their occurrence affects mainly the continuity of chemotherapy. Influenza was associated with a relevant rate of hospitalization and pneumonia compared with other CARV. Marked variability emerged regarding oncological treatment interruptions and the use of Oseltamivir. Influenza vaccination was strongly recommended to contacts, while indications for patients differ among centres. Findings highlight the lack of standardized approaches to CARV management and reinforce the importance of influenza vaccination.
// Source
Authors: Nicoletta Abram, Davide Leardini, Valeria Petroni, Paola Muggeo, Gianluca Boscarol, Rosamaria Mura, Francesca Trevisan, Maria Rosaria D’Amico, Lorenzo Chiusaroli, Giulia Angela Restivo, Angelica Barone, Francesca Compagno, Letizia Pomponia Brescia, Manuela Spadea, Laura Eliana Gazzola, Ilaria Liguoro, Federico Mercolini, Simone Cesaro
Institutions: University of Bari Aldo Moro, University of Padua, Azienda USL di Bologna, Policlinico San Matteo Fondazione, University of Bologna, Ospedale SS. Annunziata, University of Udine, Meyer Children's Hospital, Ospedale di Parma, Ospedale Regina Margherita, Ospedale Santa Chiara, Azienda di Rilievo Nazionale ed Alta Specializzazione, Azienda Ospedaliera Universitaria Pisana, Azienda Ospedaliera Universitaria Integrata Verona, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Azienda Ospedaliera G. Brotzu, Ospedale di Bolzano